Suchergebnisse - "Tabak, Fehmi"

PubPharm (321)

11

Kidney function on admission predicts in-hospital mortality in COVID-19

enthalten in: bioRxiv.org | 2022

von Trabulus, S. | Karaca, C. | İnanç Balkan, �. | +10

12

Incidence, Risk Factors, and Prognosis of Bloodstream Infections in COVID-19 Patients in Intensive Care : A Single-Center Observational Study

enthalten in: Journal of intensive care medicine | 2022

von Kurt, A. | Mete, B. | Urkmez, S. | +10

13

Efficacy and Safety of Direct-Acting Antivirals in Elderly Patients with Chronic Hepatitis C : A Nationwide Real-Life, Observational, Multicenter Study from Turkey

enthalten in: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology | 2022

von Önlen, Y. | Bal, T. | Çabalak, M. | +42

14

Remdesivir treatment for patients with moderate to severe COVID-19

enthalten in: Turkish journal of medical sciences | 2022

von Hasanoğlu, �. | Güner, R. | Çelik, �. | +18

15

Long-term follow-up of treatment-naïve HBeAg-negative patients with chronic hepatitis B

enthalten in: Irish journal of medical science | 2022

von Ozdemir, Y. | Sahin Ozdemir, M. | Bayramlar, O. | +7

16

Human immunodeficiency virus type 1 impairs sumoylation

enthalten in: Life science alliance | 2022

von Mete, B. | Pekbilir, E. | Bilge, B. | +5

17

Safety of SARS-CoV-2 vaccination in patients with Behcet's syndrome and familial Mediterranean fever : a cross-sectional comparative study on the effects of M-RNA based and inactivated vaccine

enthalten in: Rheumatology international | 2022

von Ozdede, A. | Guner, S. | Ozcifci, G. | +11

18

Ruxolitinib in addition to standard of care for the treatment of patients admitted to hospital with COVID-19 (RUXCOVID) : a randomised, double-blind, placebo-controlled, phase 3 trial

enthalten in: The Lancet. Rheumatology | 2022

von Han, M. | Antila, M. | Ficker, J. | +17

ErratumIn: Lancet Rheumatol. 2024 Mar;6(3):e140. - PMID 38383086

19

Safety of SARS-CoV-2 vaccination in patients with Behcet’s syndrome and familial Mediterranean fever: a cross-sectional comparative study on the effects of M-RNA based and inactivated vaccine

enthalten in: Rheumatology international | 2022

von Ozdede, A. | Guner, S. | Ozcifci, G. | +11

20

Safety of SARS-CoV-2 vaccination in patients with Behcet’s syndrome and familial Mediterranean fever: a cross-sectional comparative study on the effects of M-RNA based and inactivated vaccine

enthalten in: Rheumatology international | 2022

von Ozdede, A. | Guner, S. | Ozcifci, G. | +11